Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPTV in Advanced and Refractory Multiple Myeloma
NCT00358020Phase 2Completed
- Sponsor
- University of Turin
- Start
- Nov 2004
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by University of Turin. Started Nov 2004; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00358020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00358020.